LONG-TERM INCENTIVE PLAN AWARDS (Tables)

6 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of stock option activity

Options	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (In Years)		Aggregate Intrinsic Value
Outstanding as of June 30, 2023		647,001		$	4.24		2.88	$	130,200
Granted		–			–		–		–
Exercised		–			–		–		–
Cancelled		–			–		–		–
Forfeited or expired		(16,000	)		4.77		–		–
Outstanding as of December 31, 2023		631,001		$	4.23		2.38	$	–
Exercisable as of December 31, 2023		509,449		$	4.43		2.24	$	2,454

The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based upon the Company’s closing stock price of 3.39 as of December 31, 2023, which would have been received by the option holders had all option holders exercised their options as of that date. The weighted-average grant-date fair value of stock options outstanding as of December 31, 2023, in the amount of 631,001 shares was $3.34 per share. As of December 31, 2023, there was unrecognized compensation cost of $345,426 related to non-vested stock options granted.

A summary of the status of our stock options is presented below as of December 31, 2022:

Options	Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life (In Years)		Aggregate Intrinsic Value
Outstanding as of June 30, 2022		766,001		$	3.85		3.37	$	183,270
Granted		–			–		–		–
Exercised		(100,000	)		1.34		–		–
Cancelled		–			–		–		–
Forfeited or expired		(16,000	)		5.40		–		–
Outstanding as of December 31, 2022		650,001		$	4.24		3.37	$	401,760
Exercisable as of December 31, 2022		352,475		$	4.68		3.05	$	134,898